`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`BRECKENRIDGE PHARMACEUTICAL, INC.
`
`Petitioner
`
`V.
`
`NOVARTIS PHARMACEUTICALS CORPORATION
`
`Patent Owner
`
`Case IPR2017—01592
`
`U.S. Patent No. 8,410,131
`
`
`DECLARATION OF FU L. LUAN, M.D.
`
`Breckenridge Exhibit 1119
`Luan Declaration
`
`Breckenridge v. Novartis IPR 2017-01592
`
`
`
`I, Fu L. Luan, declare as follows:
`
`I.
`
`I am a transplant nephrologist affiliated with the Saint Barnabas
`
`Medical Center located at 94 Old Short Hills Road, Livingston, NJ 07039.
`
`2.
`
`I am being compensated for my time connected with this matter at my
`
`hourly rate of$174.00/hr.
`
`3.
`
`I am the first—named author of Abstract# 428 entitled "Sirolimus
`
`Prevents Tumor Progression: mTOR Targeting For The Inhibition Of Neoplastic
`
`Progression" (the ”Luan Abstract”) the results of which were presented at a joint
`
`meeting of the American Society of Transplantation and the American Society of
`
`Transplant Surgeons (”Transplant 2001”) held in Chicago, Illinois on May 11—16,
`
`2001.
`
`4.
`
`I received a Young Investigators Award based on the results presented
`
`in the Luan Abstract.
`
`5.
`
`I understand that the Luan Abstract is found at page 001 of EX. 1005
`
`filed in the above-styled Inter Partes Review (IPR2017-0 1 5 92).
`
`6.
`
`The Luan Abstract was included in a "Program Book" containing all
`
`abstracts to be presented during Transplant 2001. The Program Book was entitled
`
`"Transplant 2001: The Joint American Transplant Meeting," and it was provided to
`
`attendees of Transplant 2001.
`
`7.
`
`The Luan Abstract was publicly available as a printed publication at the
`
`time of the Transplant 2001 meeting in May of 2001.
`
`l
`
`Breckenridge Exhibit 1119
`Luan Declaration
`
`Breckenridge v. Novartis IPR 2017-01592
`
`
`
`I declare under penalty of perjury under the laws of the United States of
`
`America that the foregoing is true and correct.
`
`Dated: January 19, 2018
`
`
`
`fl"
`
`Fu L. Luan, MD.
`
`Breckenridge Exhibit 1119
`Luan Declaration
`
`Breckenridge v. Novartis IPR 2017-01592
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
